Owning and running a plastic surgery practice in the United States is about much more than surgical skill. It is also about building a sustainable business that can grow, evolve, and eventually transition to the next generation of surgeons. For many practices, the biggest challenge comes when it is time to decide how ownership, equity, and profits should be shared—or passed on—between senior surgeons, junior associates, and new partners.
The structure you choose for ownership has lasting consequences. It affects not only financial outcomes but also day-to-day decision-making, the ability to recruit and retain top talent, and the long-term reputation of the practice. Whether a surgeon is just starting to bring in associates or preparing for retirement, having a clear equity model in place helps protect both business stability and patient continuity.
This article explores the most common ownership and equity structures in private plastic surgery practices in the US – from solo ownership and associate models to more complex arrangements like LLC partnerships, performance-based equity, and hybrid approaches. By weighing the pros and cons of each, surgeons can choose a model that aligns with their goals, safeguards the practice, and ensures the best possible future for both patients and staff.
Plastic surgery practice ownership has evolved dramatically over the past two decades. Traditionally, most clinics were single-surgeon entities where ownership and decision-making were simple. Today, ownership structures are more diverse, reflecting changes in economics, patient demand, and workforce expectations.
Several trends shape modern equity models:
Shift to Group Practices: Rising overhead costs and regulatory demands have pushed many solo surgeons to form partnerships or groups.
Growth of MedSpa Services: Non-surgical services like injectables and lasers now account for a large share of revenue in many practices. This often requires parallel ownership structures, since non-physician investment may be allowed in non-surgical entities.
Private Equity and Consolidation: In the US especially, private equity firms have entered the market, offering high valuations but changing the dynamics of ownership and control.
Generational Change: Younger surgeons often value work-life balance, digital marketing, and flexible hours differently than their senior counterparts, influencing the type of succession models chosen.
Before equity can be transferred, the practice must be valued fairly. In plastic surgery, valuation is not just about revenue or assets—it also includes intangible factors such as patient goodwill and digital presence.
Key valuation drivers include:
Financial Performance: Revenue, EBITDA, and profit margins.
Patient Base: Number of active patients, referral patterns, and repeat procedures.
Reputation and Brand: Online reviews, surgeon prestige, community standing.
Non-Surgical Revenue: Contribution from MedSpa or aesthetic services.
Digital Assets: Website traffic, SEO rankings, and social media platforms.
Real Estate: If the practice owns its premises, this may be valued separately.
Independent valuation by a healthcare-specialist advisor protects both senior and junior surgeons from disputes.
Here are 11 different models for the operation of a Plastic Surgery Practice.
Pros
Full control over decision-making.
Retains 100% of profits and goodwill.
Simple structure with minimal complexity.
No risk-sharing with partners.
Harder to build succession or continuity.
Practice value is tied entirely to one surgeon’s reputation.
Pros
Increases practice capacity without giving up equity.
Predictable costs with salary/bonus structure.
Senior surgeon retains full control.
Associates may lack long-term loyalty if no ownership path exists.
Limited incentive for associates to build practice value.
Higher turnover risk.
Pros
Creates a clear career pathway for associates.
Phased buy-in eases financial burden for juniors.
Senior surgeon retains control until full buy-in is complete.
Requires transparent valuation to avoid disputes.
The transition period can be long and complex.
Risk if the junior surgeon cannot secure financing.
Pros
Aligns partners as equals in ownership, profits, and responsibilities.
Strong incentive for teamwork and shared practice growth.
Easier to attract and retain top talent.
Deadlocks are possible (e.g., 50/50 split).
Requires strong governance and conflict resolution agreements.
Productivity and Personality differences can cause tension.
Pros
Senior surgeon retains control while introducing new talent.
Junior surgeon gains stake without assuming full responsibility.
Flexibility to gradually shift control over time.
Minority owners may feel undervalued or excluded from decisions.
Risk of resentment if profit distributions are unequal.
It can discourage collaboration if control is one-sided.
Pros
Aligns ownership with measurable contributions.
Motivates junior surgeons to perform at high levels.
Senior surgeon maintains oversight during transition.
Performance criteria can be subjective or disputed.
Pressure to “hit numbers” may strain relationships.
Slower pathway to full ownership.
Pros
Incentivises associates without diluting ownership.
Flexible and easy to adjust annually.
Encourages productivity without long-term obligations.
No asset-building for a junior surgeon.
Does not solve succession or continuity issues.
May lead to turnover if surgeons want ownership.
Pros
Allows financial upside without giving up control.
Attractive for associates who want stability but not management.
Can help retain key staff or surgeons.
Holders may feel excluded from decision-making.
Limited long-term influence on practice direction.
Complexity in structuring classes of shares.
Pros
Flexible structure with voting vs. non-voting stock.
Scales well for larger or multi-specialty practices.
Easier to bring in or buy out shareholders.
More administrative complexity.
Requires careful shareholder agreements.
Disputes can arise over dividends, control, or exit terms.
Pros
High flexibility in structuring ownership, profits, and voting rights.
Protects partners with limited liability.
Well-suited for practices with multiple surgeons.
Requires a detailed operating agreement to avoid disputes.
State law variations can complicate structure.
More expensive legal/accounting setup.
11A. Owner + Associates + MedSpa Spin-Off
11B. Phantom Equity / Shadow Shares
Pros
11C. Management Service Organization (MSO)
Equity ownership does not automatically clarify how decisions are made. A well-designed governance structure ensures fairness, stability, and smooth daily operations.
Governance elements include:
Voting Rights: Whether votes are equal or weighted by ownership percentage.
Decision Thresholds: Which decisions require majority, supermajority, or unanimous approval.
Management Roles: Who serves as medical director, managing partner, or board chair.
Profit Reinvestment: Guidelines for retaining profits to grow the practice.
Conflict Resolution: Arbitration or mediation clauses to prevent disputes escalating to litigation.
Without clear governance, even strong ownership models can break down under pressure.
| Model | Equity % | Voting Rights | Profit Share | Best Suited For | Key Risks |
|---|---|---|---|---|---|
| Solo Practitioner | 100% to one surgeon | Full control | 100% to the owner | Independent surgeons want full authority | No risk-sharing; succession is difficult |
| Associate / Employee | 0% | None | Salary + bonus | Practices expanding capacity without equity dilution | Low loyalty; high turnover if no ownership path |
| Associate-to-Partner Buy-In | Gradual (10–50%+) | Proportional, senior retains control until full buy-in | Salary + collections → ownership % | Mentorship and long-term succession | Financing hurdles; prolonged transition |
| Equal Partnership | Typically 50/50 or 33/33/33 | Equal, consensus needed | Equal or adjusted for productivity | Surgeons aligned in goals and workload | Deadlocks; tension if productivity differs |
| Majority–Minority | Senior 60–80%, Junior 20–40% | Weighted to equity % | Distributed by ownership % | Senior surgeon not ready to relinquish control | Minority may feel sidelined; control imbalance |
| Tiered Equity / Performance-Based | Earned incrementally | Senior retains oversight until targets met | Salary + bonus + equity-linked | High-performing juniors tied to practice growth | Subjective targets; pressure on juniors |
| Profit-Share Without Equity | 0% | None | Fixed % of profits or productivity-based | Retaining senior associates without equity dilution | No asset building; no succession planning |
| Non-Voting Equity Shares | 10–40% typical | Senior retains all voting | Pro-rata based on equity | Providing upside without control | Non-voters may feel excluded; complex share classes |
| Shareholder / Corporate (S-Corp or C-Corp) | Divided into shares | Voting & non-voting stock possible | Dividends or salary + bonus | Larger, multi-specialty, growth-focused practices | Administrative complexity; shareholder disputes |
| Multi-Partner LLC / LLP | Flexible, defined in agreement | Equal or proportional | Pro-rata or customized | Multi-surgeon practices need flexibility | Requires airtight agreements; state law variations |
| Hybrid & Alternatives (MedSpa Spin-Off, Phantom Equity, MSO) | Varies (MedSpa allows non-MD investors) | Depends on the entity | Surgical profits are separate from non-surgical | Practices diversifying into MedSpa or scaling multi-site | Complex compliance; investor vs. surgeon tension |
Q: How is goodwill valued in a plastic surgery practice where the founder’s personal reputation drives most of the patients?
Goodwill is a major part of valuation, but tricky when a practice is tied to one surgeon’s name. A valuation expert may discount goodwill if patients are unlikely to stay after the senior surgeon retires. Rebranding or co-branding the practice before transition can help preserve goodwill value.
Q: Can non-surgical revenue streams like injectables or MedSpa services be valued separately from the surgical practice?
Yes. Many practices split surgical and non-surgical entities for legal, tax, or investment reasons. MedSpa services may attract different valuation multiples because they can operate without the same physician ownership restrictions.
Q: What happens if the real estate (the clinic building) is owned by the senior surgeon?
Often, the property is held in a separate LLC or trust. The retiring surgeon can lease the space to the practice for steady income or sell it separately. Ownership of real estate should be addressed independently of clinical equity.
Q: Can equity be transferred at below fair market value to a junior surgeon as a mentorship or legacy gift?
Yes, but tax implications must be considered. In the US, the IRS may treat the discount as a gift, which can trigger gift tax obligations.
Q: How do practices protect themselves if the junior surgeon’s financing falls through after signing agreements?
Buy-sell contracts should include contingencies — such as reversion of equity, extended payment schedules, or forfeiture clauses — to protect the senior surgeon.
Q: Can a spouse or family member who is not a surgeon own part of the practice?
In most US states, no. State corporate practice of medicine laws generally restrict ownership to licensed physicians. However, non-surgeons can sometimes own stakes in management service organizations (MSOs) or real estate holding entities.
Q: How do non-compete clauses work in succession agreements?
Enforceability varies widely by state. Some states (e.g., California) currently ban most non-competes. Others allow them if they are reasonable in scope and duration. Succession agreements should also include non-solicitation clauses to protect patient lists and staff.
Q: What happens to malpractice liability after ownership transfer?
The incoming surgeon is responsible for new cases, but the senior surgeon may need “tail coverage” to protect against claims from procedures performed before retirement. This cost should be factored into succession planning.
Q: Can an equity transfer agreement fail state medical board approval?
Yes. If it violates ownership laws, fee-splitting rules, or patient care standards, boards can intervene. Agreements should always be reviewed by healthcare counsel familiar with local regulations.
Q: What if two junior surgeons want to buy in at different times?
Ownership can be staggered, but it complicates governance. Agreements must define how future equity is priced and prevent resentment between partners who bought in at different valuations.
Q: Can voting rights be separated from profit shares?
Yes. Senior surgeons often retain majority voting power even while selling profit rights to juniors. This allows them to maintain strategic control during the transition period.
Q: What if one partner wants to invest profits into expansion while the other prefers higher personal payouts?
Operating agreements should define profit reinvestment policies upfront, or disputes will arise. Some practices require supermajority approval for large capital expenditures.
Q: Can equity transfers include trial periods?
Yes. Some agreements use probationary or trial buy-in phases with clawback provisions, where equity reverts to the senior surgeon if the arrangement fails.
Q: How do you introduce new equity partners to patients without making it sound like the founder is “stepping away”?
Messaging should emphasize continuity, growth, and collaboration. Co-branded marketing, joint consultations, and gradual introductions reassure patients that quality of care will remain high.
Q: What if staff are loyal to the senior surgeon and resist working under new ownership?
Retention bonuses, clear communication, and defined roles help maintain morale. Succession planning should include culture-building, not just financial arrangements.
Q: Can ownership transfers affect staff contracts?
Yes. Employment agreements may need to be reissued under the new ownership entity, especially in states with strict employment laws.
Q: What happens if the senior surgeon passes away before the transfer is complete?
Without a buy-sell agreement, ownership may pass to heirs who cannot legally own the practice. Life insurance policies are often used to fund buy-outs in these situations.
Q: How do equity models handle unexpected disability of a surgeon?
Buy-sell agreements should define “disability events” and provide for buy-out or insurance-triggered funding to prevent financial strain on the practice.
Q: What if patients don’t transition to the new surgeon?
Earn-out structures or phased handovers can link payouts to patient retention, aligning incentives between senior and junior surgeons.
Q: Can succession fail completely?
Yes. Disputes over valuation, personality conflicts, or financing failures can derail transitions. Backup plans — including external sale or merger — should always be considered.
Q: What if the practice is named after the senior surgeon?
Rebranding may be necessary for long-term stability. Co-branding (e.g., “Smith & Lee Plastic Surgery”) during transition can help transfer patient loyalty.
Q: Can junior surgeons be given equity but not leadership roles?
Yes. Non-voting or limited-voting equity can provide financial upside while leaving leadership with senior partners until the junior gains more experience.
Q: What if one surgeon wants to expand aggressively into non-surgical ventures while others want to focus on surgery?
Clear agreements must define how side businesses are handled — whether they belong to the practice or remain personal ventures.
Q: How do generational differences affect ownership models?
Younger surgeons may emphasize marketing, branding, and digital strategies, while seniors may value reputation and referrals. Succession plans should balance both approaches.
Q: Can succession planning incorporate legacy or philanthropy?
Yes. Some surgeons allocate part of their buy-out proceeds to scholarships, foundations, or community projects, ensuring their legacy continues beyond clinical practice.
Q: How are digital assets like websites, patient email lists, and social media valued?
They are increasingly considered part of goodwill. Independent valuation should include analytics, search rankings, and online engagement metrics.
Q: Who owns the patient database during equity transfer?
The practice owns patient records, but agreements must comply with HIPAA. Transfers should be carefully structured to protect patient privacy.
Q: What if the new surgeon wants to overhaul the website and branding immediately?
A staged approach is often safer. Abrupt changes can harm SEO rankings and disrupt patient trust. Joint branding during the transition is usually best.
Choosing the right equity and ownership model is not simply a legal or financial exercise. It is a strategic decision that influences the culture, performance, and legacy of a plastic surgery practice. Models that work well for one clinic may not fit another, and the right solution often depends on the personalities, ambitions, and financial circumstances of the surgeons involved.
The most successful practices are those that plan succession early, define clear agreements, and update those agreements as circumstances and regulations change. Transparency around valuation, profit distribution, and governance helps avoid disputes and ensures a smooth transition from one generation of surgeons to the next.
Ultimately, equity transfer is about more than money—it is about continuity of care, stability for staff, and preserving the hard-won reputation of a practice. By carefully considering the available models and seeking advice from experienced legal, tax, and practice management professionals, surgeons can create ownership structures that protect their business, reward their efforts, and secure the future of their practice.
Disclaimer: This article is for educational purposes only. It is not legal advice. Each state, country, and jurisdiction has its own healthcare and corporate laws. Always seek independent legal, tax, and financial advice before entering into any ownership changes or equity transfer arrangements.